| |
|
|
|
Acasti Pharma  
|
|
0.2093 -0.028 (-0.12%) |
09-23 16:00 |
|
Open: |
0.2247 |
Pre close: |
0.2376 |
Target:
|
0.68
|
|
High: |
0.2298 |
Low: |
0.205 |
Resistance:
|
0.58
0.83
|
|
Volume: |
8,029,582 |
Market Cap: |
20M |
Support:
|
0.18
0.15
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.23
 |
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
0.29  |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
0.61 |
Stochastic Oscillator |
%K(14,3):
|
52.58 |
|
MA(250): |
1.01 |
%D(3): |
43.42 |
|
Average Volume(K) |
3-Month: |
606131
|
52-Week |
High:
|
3.08 |
|
10-Days: |
1055957 |
Low: |
0.18 |
|
RSI |
RSI(14):
|
31.39 |
Change(%): |
-88.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.244 |
Return on Equity (ttm) |
-310.0 |
Shares Out. (M) |
96.89 |
|
EPS Est. Current Year |
-0.730 |
Return on Assets (ttm) |
-53.8 |
Shares Float (M) |
93.52 |
|
EPS Est. Next Year |
-0.770 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.29 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
6.09 |
|
Forward EPS |
-0.714 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
452 |
|
Book Value (p.s.) |
0.120 |
EBITDA (p.s.) |
-0.197 |
P/E |
-0.86 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.74 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-20.43 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.98 |
P/CF |
-0.99 |
|
|
|
|
|
|
